New program helps latino cancer patients voice their care wishes

NCT ID NCT04889144

Completed Knowledge-focused Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a program called PLAN to help Latino cancer patients plan for their future medical care. Twenty-seven patients with advanced cancer took part. The program aimed to improve their understanding and communication about advance care planning with doctors and family. Researchers measured how helpful and feasible the program was.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Planning for Your Advance Care Needs (PLAN) intervention
What this could lead to: If successful, this program could help Latino cancer patients better understand and communicate their care wishes, leading to more personalized end-of-life care.
What could go wrong: This was a small, early feasibility study with only 27 participants. Results may not apply to all Latino patients, and the program may not improve actual care outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED MALIGNANT SOLID NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Communication metastatic malignant neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED MALIGNANT SOLID NEOPLASM METASTATIC MALIGNANT SOLID NEOPLASM

Contacts and locations

Locations

Confluence Health

Wenatchee, Washington, 98801, United States
Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States
UT Southwestern/Simmons Cancer Center-Dallas

Dallas, Texas, 75390, United States
Weill Cornell Medicine

New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.